A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

NCT01720524 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension, Familial Persistent, of the Newborn

Interventions

DRUG: placebo
DRUG: iv sildenafil

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.